Skip to main content

Table 1 Demographics of SLE and RA patients and healthy donors

From: Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients

 

SLE patients (n = 67)

RA patients (n = 20)

Healthy donors (n = 23)

Age (years)

35.43 ± 1.85 (14–60)

37.2 ± 1.68 (17–61)

32.21 ± 2 (16–58)

Sex (%)

   

   Female

89.6

85

83.3

   Male

10.4

15

16.7

Disease duration (years)

5.58 ± 0.75 (0.04–24)

5.93 ± 1.3 (1.2–21)

-

ANA (%)

95.5

37.1

-

SLEDAI-2K

8.06 ± 0.68 (0–25)

-

-

SDI

0.82 ± 0.17 (0–6)

-

-

  1. Except where otherwise indicated, values are expressed as mean ± standard error of the mean (range). There were no significant differences between patients with SLE, patients with RA and healthy donors in terms of age and sex. ANA, antinuclear antibody; RA, rheumatoid arthritis; SDI, Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index; SLE, systemic lupus erythematosus; SLEDAI-2K, SLE Disease Activity Index 2000.